Search Job Title Only
News By Subject
News by Disease
News By Date
Get Our FREE
Remediation To Continue Through 2014 At
)'s Rocky Mount
11/11/2013 7:30:37 AM
Remediation at troubled Rocky Mount facility will continue into 2014 Hopira says as it awaits an inspection by the US Food and Drug Administration (FDA).
Help employers find you! Check out all the
post your resume
(HSP) Shares Results From Two Open-label Extension Studies for Biosimilar Infliximab in Patients With Rheumatoid Arthritis or Ankylosing Spondylitis
(GSK) Reveals Winners of Its First Academic Drug Hunter Program
U.S. Defense Dept.
Awards $84 Million in Contracts to Medical Device COs Such as
Cardinal Health, Inc.
Henry Schein, Inc.
Put Down That Doughnut:
Takes on Trans Fats
(HSP) Launches Q Core Sapphire Infusion System in the United States
How One Biotech Company,
(ALKS), Survived A Brush With Death
Sounds the Alarm on
(HSP) Blood Kits After 1 Patient Dies
Whistleblowers Worked Undercover at
Johnson & Johnson
(JNJ) to Expose Huge Scam
(HSP)'s Inflectra (infliximab) the First Biosimilar Monoclonal Antibody to be Approved in Europe
Where, Oh Where, Did the Clinical Trials Go? One-Third Remain Unpublished After Five Years
comments powered by Disqus.
comments powered by
Biotech/Pharma - Regulatory